Viva Biotech Holdings (FRA:VB0) Total Assets : €956.8 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Viva Biotech Holdings Total Assets?

Viva Biotech Holdings's Total Assets for the quarter that ended in Dec. 2023 was €956.8 Mil.

Warning Sign:

If a company builds assets at 78.8% a year, faster than its revenue growth rate of 58.4% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Viva Biotech Holdings's average Total Assets Growth Rate was -13.30% per year. During the past 3 years, the average Total Assets Growth Rate was 0.70% per year. During the past 5 years, the average Total Assets Growth Rate was 78.80% per year.

During the past 8 years, Viva Biotech Holdings's highest 3-Year average Total Assets Growth Rate was 224.90%. The lowest was 0.70%. And the median was 121.30%.

Total Assets is connected with ROA %. Viva Biotech Holdings's annualized ROA % for the quarter that ended in Dec. 2023 was -3.00%. Total Assets is also linked to Revenue through Asset Turnover. Viva Biotech Holdings's Asset Turnover for the quarter that ended in Dec. 2023 was 0.13.

Viva Biotech Holdings Total Assets Historical Data

The historical data trend for Viva Biotech Holdings's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Viva Biotech Holdings Total Assets Chart

Viva Biotech Holdings Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

243.65

1,024.98

1,117.80

1,072.52

956.78

Viva Biotech Holdings Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Total Assets	Get a 7-Day Free Trial										1,151.92	1,072.52	1,050.10	956.78	-

Viva Biotech Holdings Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Viva Biotech Holdings's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	473.63	+	483.145
	=	956.8

Viva Biotech Holdings's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	473.63	+	483.145
	=	956.8

Viva Biotech Holdings (FRA:VB0) Total Assets Explanation

Total Assets is connected with ROA %.

Viva Biotech Holdings's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	-30.084	/	( (1050.1	+	956.776)	/ 2 )
	=	-30.084	/	1003.438
	=	-3.00 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Viva Biotech Holdings's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	130.148	/	( (1050.1	+	956.776)	/ 2 )
=	130.148	/	1003.438
=	0.13

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Viva Biotech Holdings Total Assets Related Terms

Thank you for viewing the detailed overview of Viva Biotech Holdings's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Viva Biotech Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Viva Biotech Holdings (FRA:VB0) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

VBIZF:USA 01873:Hong Kong

Address

735 Ziping Road, Pudong New District, Zhoupu Town, Shanghai, CHN, 201318

Website

https://www.vivabiotech.com

Viva Biotech Holdings is an integrated drug discovery platform. The company's operating segment includes Drug discovery services and Contract Development Manufacture Organisation (CDMO) and commercialisation services. It generates maximum revenue from the Contract Development Manufacture Organisation (CDMO) and commercialisation services segment. The Contract Development Manufacture Organisation (CDMO) and commercialisation services segment include contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates, and formulations. Geographically, the company generates a majority of its revenue from the United States of America, and the rest from the European Union, Chinese Mainland, Africa, and other regions.

Viva Biotech Holdings Headlines

No Headlines